维普中文期刊产品整合服务
32篇 您的检索式:作者名="VIVALDI A"
    题名 作者 年代 出处 被引量
1Retinoic acid rece tor beta re-expressi-on and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment显示文摘Miasaki FY Vivaldi A Ciampi R 2008J Endocrinol Invest2008,31,8:1
2Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid显示文摘Vivaldi A Miasaki FY Ciampi R 0,,:1
3All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes显示文摘 Vivaldi A Agate L 2005Clin Endocrinol Metab2005,90,4:1
4Simian virus 40-like DNA sequences in human papillary thyroid carcinomas 显示文摘Pacini F Vivaldi A Santoro M 1998Oncogene1998,16,5:1
5Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors显示文摘Ciampi R Vivaldi A Romei C 2008Mol Cell Endocrinol2008,291,12:1
6Simian virus 40-like sequencesfrom early and late regions in human thyroid tumors of different his-totypes 显示文摘Vivaldi A Pacini F Martini 2003The Journal of Clinical Endocrinology & Metabolism2003,88,2:1
7Celecoxib,a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine inthe medullary thyroid cancer TT cell line 显示文摘A Vivaldi R Ciampi A Tacito 2012Mol Cell Endocri-nol2012,355,1:1
8Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer显示文摘Cristaudo A Foddis R Vivaldi A 2007Clin Cancer Res2007,13,17:1
9Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2’-deoxycytidine and retinoic acid显示文摘Vivaldi A Miasaki FY Ciampi R 2009Mol Cell Endocrinol2009,307,12:1
10Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors显示文摘CIAMPI R VIVALDI A ROMEI C 2008Mol Cell Endocrinol2008,291,:1
11Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent显示文摘Leers JM Vivaldi C Sch(a)fer H 0,,:1
12Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line 显示文摘Vivaldi A Ciampi R Tacito A 2012Mol Cell Endocrinol2012,355,1:1
13All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes 显示文摘Elisei R Vivaldi A Agate L 2005Clin Endocrinol Metab2005,90,4:1
14Clinical significance of serum MSLN in patients with mesothelioma and lung cancer显示文摘Cristaudo A Foddis R Vivaldi A 2007Clin Cancer Res2007,13,17:1
15Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transletted with sodium iodide symporter complementary deoxyribonucleic acid显示文摘ELISEI R VIVALDI A CIAMPI R 2006J Clin Endocrinol Metab2006,91,6:1
16Low specificity ofblood thyroglobulin messenger ribonucleic acid assay preventsits use in the follow-up of differentiated thyroid cancerpatients显示文摘ELISEI R VIVALDI A AGATE L 2004J Clin Endocrinol Metab2004,89,1:1
17Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer T cell line 显示文摘Vivaldi A Ciampi R Tacito A 2012Mol Cell Endocrinol2012,355,1:1
18Simian virus 40-like sequences from early and late regions in human thyroid minors of different histotypes显示文摘Vivaldi A Pacini F Martini F 2003J Clin Endocrinol Metab2003,88,2:1
19Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer显示文摘Cristaudo A Foddis R Vivaldi A 2007Clin Cancer Res2007,13,17:1
20The efficacy of a fluoride varnish in reducing enamel demineralization adjacent to orthodontic brackets:an in vitro study 显示文摘Demito C F Vivaldi Rodrigues G Ramos A L 2004Othod Craniofac Res2004,7,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费